COMMUNICATION
News & Press Release
Neurobiogen, enters phase 2 clinical trial for Alzheimer's drug candidate.
- DATE : 2024-09-02
- VIEWS : 2271
FILES
- Add(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
- Tel+82-70-4018-8009
- Fax+82-02-3486-2613
- E-mailneuro_reply@neurobiogen.com
FAMILY SITE
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved